PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The value of randomized clinical trials in radiation oncology clinical practice

2013-05-29
(Press-News.org) CHAPEL HILL, N.C. - Cancer patients, physicians and insurers want to be sure that whatever therapy is recommended and provided to patients is based on evidence, preferably results from randomized clinical trials. But are there enough clinical trials data to provide this level of confidence?

A University of North Carolina School of Medicine study says not necessarily. Radiation oncologists evaluated how often patients were seen in their clinic with medical decisions to be made that were not specifically addressed by randomized controlled trials.

They determined that in a group of 393 patients who were being treated with curative intent with multiple tumor types, 47 percent of all medical decisions were made without available or applicable randomized evidence to inform clinical decision making.

The study is the only known published study to evaluate the availability of evidence in a routine clinical setting for any medical specialty. It was published in the June issue of the journal Cancer.

"Randomized controlled trials are the lynchpin of clinical care, but the results are often not applicable to an individual patient, so all care cannot be provided entirely on the basis of those trials. We're not speaking against clinical trials. We're just pointing out their limitations in daily cancer care," said Joel Tepper, MD, senior author. Dr. Tepper is Hector McLean Distinguished Professor of Cancer Research, professor of radiation oncology and a member of UNC Lineberger Comprehensive Cancer Center.

Dr. Tepper said the study draws attention to several issues. "The potential negative consequences of evidence-based coverage policies may impede necessary and appropriate patient care. If the standard of adequate evidence in the form of randomized clinical trials are often not generalizable to patients, the appropriateness of using randomized data as the basis for coverage of every patient comes into question." Observational studies, trials conducted without randomization, are an option to inform decisions when randomized trials are not available.

"Additionally, we hope that our study results suggest that well-designed observational studies and alternative clinical trial designs may play a central role in the continued development of evidence for medical decision making in select patient groups," said Dr. Tepper. It also emphasizes the need for a robust clinical trial system that will generate more randomized trial data to inform clinical decision making.

"Our results also emphasize the importance of clinical judgment and experience in what we recommend to our patients. Tumor boards, when a patient's case is evaluated by a number of medical specialties, can also be extremely useful," he said.

The UNC group reviewed medical records of 393 patients evaluated for treatment in the UNC radiation oncology clinic. Patients with cancer of the breast (30 percent), head and neck (18 percent), and genitourinary (14 percent) were the most common tumor types included in the study. Patient medical decisions were classified as those with (Group 1) or without (Group 2) randomized clinical trials data. Group 1 was further divided into three groups based on the extent of fulfilling eligibility criteria for each randomized clinical trial: 1a) fulfilling all eligibility criteria; 1b) not fulfilling at least one minor eligibility criteria; and 1c) not fulfilling at least one major eligibility criteria. The availability of high level evidence varied by tumor type.



INFORMATION:

Other study authors are Smith Apisarnthanarax, MD, and Samuel Swisher-McClure, MD, University of Pennsylvania Abramson Cancer Center in Philadelphia; Randall Kimple, MD, PhD, University of Wisconsin in Madison; Stephen Harris, MD, Radiation Oncology Associates, Manchester, New Hampshire; David Morris, MD, St. Louis CyberKnife Center in St. Louis, Missouri and Wing Chiu, PhD, UNC.



ELSE PRESS RELEASES FROM THIS DATE:

Re-creating the original colors of treasured ivory carvings from the ancient past

2013-05-29
The fabled ivory carvings from the ancient Phoenician city of Arslan Tash — literally meaning "Stone Lion" — may appear a dull monochrome in museums today, but they glittered with brilliant blue, red, gold and other colors 2,800 years ago, a new study has confirmed after decades of speculation. It appears in the ACS journal Analytical Chemistry. Ina Reiche and colleagues explain that these carvings are rare, housed in museums like the Louvre, and art experts regard them as the most beautiful ivory carvings of the era. Experts long believed that the lion heads, amulets ...

Nordic diet lowers cholesterol, study finds

2013-05-29
A healthy Nordic diet lowers cholesterol levels, and therefore the risk of cardiovascular disease, a pan-Nordic study where Lund University participated has found. There was also decreased inflammation associated with pre-diabetes. - The subjects who ate a Nordic diet had lower levels of harmful LDL cholesterol and higher levels of "good" HDL cholesterol. The amount of harmful fat particles in the blood also declined, says Lieselotte Cloetens, a biomedical nutrition researcher at Lund University. The 'healthy Nordic diet' used in the study contains local produce such ...

Radiotherapy remains the treatment of first choice for high-risk low-grade glioma

2013-05-29
In a large, international, randomized trial, initial radiotherapy was compared to temozolomide chemotherapy. A statistically significant difference between the two treatment strategies was not observed for progression-free survival, although radiotherapy was numerically favored. However, molecular tumor characterization may allow the treatment approach to be personalized and one or the other treatment modality to be selected. The results of EORTC trial 22033-26033 will be presented Saturday, 01 June 2013 at an ASCO 2013 Oral Abstract Session by the coordinator of the ...

Is YouTube an effective research tool?

2013-05-29
New Rochelle, NY, May 29, 2013—YouTube has more than 10 million unique users a month who are younger than 18 years of age, making it an ideal online environment in which to study the impact of various media content and peer feedback on adolescents. A series of experiments were designed to test the effectiveness of using YouTube to present controlled media content and peer comments to teens, and to measure their preferences and moral judgments. The results are presented in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal from Mary Ann Liebert, Inc., ...

Human scabs serve as inspiration for new bandage to speed healing

2013-05-29
Human scabs have become the model for development of an advanced wound dressing material that shows promise for speeding the healing process, scientists are reporting. Their study appears in the journal ACS Applied Materials & Interfaces. Shutao Wang and colleagues explain that scabs are a perfect natural dressing material for wounds. In addition to preventing further bleeding, scabs protect against infection and recruit the new cells needed for healing. Existing bandages and other dressings for wounds generally are intended to prevent bleeding and infections. Wang's ...

EORTC study identifies patients with anaplastic oligodendroglioma that benefit from adjuvant PCV

2013-05-29
A further report on the results of EORTC trial 26951 indicates that CpG island methylator phenotype (CIMP) status and O 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation as assessed by MGMT-STP27 are the most informative for identifying grade III glioma patients who might benefit from the addition of procarbazine, CCNU and vincristine (PCV) chemotherapy to radiation therapy. Prior results had shown that PCV chemotherapy following standard radiation therapy delayed tumor growth and extended the lives of patients with anaplastic oligodendroglial tumors, a ...

Charred micro-bunny sculpture shows promise of new material for 3-D shaping

2013-05-29
Though its surface has been turned to carbon, the bunny-like features can still be easily observed with a microscope. This rabbit sculpture, the size of a typical bacterium, is one of several whimsical shapes created by a team of Japanese scientists using a new material that can be molded into complex, highly conductive 3-D structures with features just a few micrometers across. Combined with state-of-the-art micro-sculpting techniques, the new resin holds promise for making customized electrodes for fuel cells or batteries, as well as biosensor interfaces for medical uses. ...

Despite safety and other concerns, nuclear power saves lives, greenhouse gas emissions

2013-05-29
Global use of nuclear power has prevented about 1.84 million air pollution-related deaths and release of 64 billion tons of greenhouse gases that would have resulted from burning coal and other fossil fuels, a new study concludes. It appears in the ACS journal Environmental Science & Technology. Pushker A. Kharecha and James E. Hansen state that nuclear power has the potential to help control both global climate change and illness and death associated with air pollution. That potential exists, they say, despite serious questions about safety, disposal of radioactive waste ...

A new addition to the Hall of Fame of science venues

2013-05-29
A building that helped launch generations of scientists, including Nobel laureates, on their careers of discovery has joined the Hall of Fame of notable venues, being named a National Historic Chemical Landmark by the American Chemical Society (ACS). That's the topic of an article in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the ACS, the world's largest scientific society. Susan J. Ainsworth, C&EN senior editor, explains that the ACS recognized the R.B. Wetherill Laboratory of Chemistry building on the Purdue University's ...

New Mayo Clinic approach could lead to blood test to diagnose Alzheimer's in earliest stage

2013-05-29
ROCHESTER, Minn. -- Blood offers promise as a way to detect Alzheimer's disease at its earliest onset, Mayo Clinic researchers say. They envision a test that would detect distinct metabolic signatures in blood plasma that are synonymous with the disease -- years before patients begin showing cognitive decline. Their study was recently published online in the journal PLOS ONE. Researchers analyzed cerebrospinal fluid and plasma samples from 45 people in the Mayo Clinic Study on Aging and Mayo Clinic Alzheimer's Disease Center (15 with no cognitive decline, 15 with mild ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] The value of randomized clinical trials in radiation oncology clinical practice